Zoonotic & Vector-Borne Diseases

Investigators from Yale School of Medicine, in collaboration with Novartis Vaccines, Inc, have developed a novel vaccine that successfully protects against malaria infection in a mouse model.

Tafenoquine is the first single-dose medicine for the prevention of P vivax malaria relapse.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The World Health Organization has listed Uganda on its Zika travel advisory list, but now the country’s health minister is requesting removal from the list, citing no cases or outbreaks.

Treatment with azithromycin plus ivermectin versus ivermectin alone provides equal protection against scabies and impetigo in at-risk communities.

In October 2016, 6 harvesters at a German vineyard fell ill after consuming pressed grapes contaminated with Francisella tularensis from infected mice.

Researchers from Northern Arizona University report that citizen participation in nationwide research can offer insight into the prevalence of vector-borne disease threats.

Samuel Shor, MD, FACP, explores the controversial concept of chronic Lyme disease and the role of antibiotic stewardship in treatment programs.

In case you missed them, we’ve compiled the top 5 infectious disease articles from this past week.

A new CDC report finds most states don’t track Chagas disease, but the agency says states should consider doing so if they have a large population of immigrants from countries where the disease is endemic.

Researchers studying how pregnant women in the United States responded to the Zika virus outbreak of 2015-2016 emphasize the need to manage stress and fear during disease outbreaks.

Samuel, Shor, MD, FACP, discusses the potential link between chronic fatigue syndrome and Lyme disease.

Stay up-to-date on the latest infectious disease news by reading the top 5 articles of the week.

A recent study finds that shortening the rabies pre-exposure prophylaxis regimen is both effective and safe.

Current research trends indicate a need for updated guidelines and new technology to differentiate between Zika and other mosquito-borne infections.

State health departments around the United States are reporting their first human and mosquito cases of West Nile virus for the 2018 season, prompting reminders to practice mosquito bite prevention.

The emergence of new species creates pressure for developing affordable and reliable diagnostic strategies.

In case you missed them, we've compiled the top 5 articles from this past week.

A new analysis finds samples of capillary blood are more likely than venous blood samples to indicate the presence of malaria.

Single-dose vaccines delivered via a new technology platform may offer full protection against Zika, Lassa fever, and Ebola.

Much about the virus and the proper public health response to outbreaks remains up for debate.

A recent study has shown that highly pathogenic avian influenza (HPAI) A(H7N9) virus is spreading westward from southern and eastern China.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

A central team led by the National Centre for Disease Control stresses that Nipah virus in India is not a major outbreak, but a local occurrence, and the situation is currently under control.

The virus associated with the Middle East may or may not pose a threat to the United States, but researchers here are still working hard to find treatments and preventative vaccines.

Researchers have found that a vaccine for Junin virus, a South American hemorrhagic fever virus, protects against another virus in the same family, opening up the possibility for universal vaccines for virus families.

In the wake of the Ebola epidemic in West Africa, the World Health Organization is working with the Center for Infectious Disease Research and Policy and the Wellcome Trust to create research & development roadmaps for priority diseases, such as Nipah virus.

The new LN34 test provided fewer false-positive results than the current gold-standard test, as well as fewer inconclusive results, and no false negative results.

The FDA has approved an additional claim for Roche’s cobas Zika virus test, allowing for the screening of several individual blood or plasma donations that have been pooled together.

A new report by Global Health Technologies Coalition assesses the economic impact of cuts to global health R&D on the economies of US states.